FDX1 and hepatocellular carcinoma: Similarly, when 58% of HCC patients were classified into the high-FDX1 group in the GSE14520 and ICGC-LIRI datasets, according to the expression of FDX1, they also had a significantly better prognosis (Figures 1I, J; p = 0.021 and p = 0.00063, respectively).